Stocks and Investing Stocks and Investing
Wed, March 8, 2023
Tue, March 7, 2023

Anupam Rama Maintained (BBIO) at Buy with Increased Target to $23 on, Mar 7th, 2023


Published on 2024-10-28 02:09:50 - WOPRAI, Anupam Rama
  Print publication without navigation


Anupam Rama of JP Morgan, Maintained "BridgeBio Pharma, Inc." (BBIO) at Buy with Increased Target from $18 to $23 on, Mar 7th, 2023.

Anupam has made no other calls on BBIO in the last 4 months.



There are 2 other peers that have a rating on BBIO. Out of the 2 peers that are also analyzing BBIO, 0 agree with Anupam's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Anupam


  • Tyler Van Buren of "Cowen & Co." Initiated at Buy on, Monday, February 6th, 2023
  • Mani Foroohar of "SVB Leerink" Maintained at Buy with Decreased Target to $19 on, Monday, January 23rd, 2023
Contributing Sources